|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/7088 | |||
| C07H 21/02 |
| (11) | Patento numeris | 3212794 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15795074.2 |
| Europos patento paraiškos padavimo data | 2015-10-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-09-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/057717 |
| Data | 2015-10-28 |
| (87) | Numeris | WO 2016/069694 |
| Data | 2016-05-06 |
| (30) | Numeris | Data | Šalis |
| 201462072686 P | 2014-10-30 | US |
| (72) |
HINKLE, Gregory, US
|
| (73) |
Genzyme Corporation,
50 Binney Street, Cambridge, MA 02142,
US
|
| (54) | POLYNUCLEOTIDE AGENTS TARGETING SERPINC1 (AT3) AND METHODS OF USE THEREOF |
| POLYNUCLEOTIDE AGENTS TARGETING SERPINC1 (AT3) AND METHODS OF USE THEREOF |